91-LB: Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study

91-LB: Once-Weekly Exenatide in Youth with Type 2 Diabetes: A Pivotal Phase III Randomized Study

Aim: To evaluate the efficacy and safety of once‑weekly exenatide (EQW) in youth with T2D. Methods: Participants (aged 10 to

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser: TAMBORLANE, WILLIAM V., BISHAI, RAAFAT, GELLER, DAVID, SHEHADEH, NAIM, AL-ABDULRAZZAQ, DALIA, KÁROLY, ÉVA, DOEHRING, ORLANDO, CARTER, DEBRA, MONYAK, JOHN, SJÖSTRÖM, C. DAVID
Format: Artikel
Sprache:eng
Schlagworte:
Adolescents
Adverse events
Antidiabetics
Blood pressure
Body weight
Clinical outcomes
Diabetes
Diabetes mellitus (non-insulin dependent)
Drug dosages
Drug therapy
Pediatrics
Placebos
Teenagers
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim: To evaluate the efficacy and safety of once‑weekly exenatide (EQW) in youth with T2D. Methods: Participants (aged 10 to
ISSN:0012-1797
1939-327X
DOI:10.2337/db21-91-LB